By analyzing the tumor clone composition and the mutational landscape of the ibrutinib-resistant cells by WES we identified, according to SIFT, deleterious variants in PIK3CD (4:149658400 A/T) and VMN2R37 (7:9206799 G/C). This evidence concerns the gene PIK3CD and neoplasm.